Cargando…
Involvement of calreticulin in cell proliferation, invasion and differentiation in diallyl disulfide-treated HL-60 cells
Diallyl disulfide (DADS) has shown potential as a therapeutic agent in various cancers. Previously, calreticulin (CRT) was found to be downregulated in differentiated HL-60 cells treated with DADS. The present study investigated the role of CRT proteins in DADS-induced proliferation, invasion and di...
Autores principales: | Yi, Lan, Shan, Jian, Chen, Xin, Li, Guoqing, Li, Linwei, Tan, Hui, Su, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998039/ https://www.ncbi.nlm.nih.gov/pubmed/27588133 http://dx.doi.org/10.3892/ol.2016.4850 |
Ejemplares similares
-
Diallyl disulfide down‐regulates calreticulin and promotes C/EBPα expression in differentiation of human leukaemia cells
por: Sun, Jing, et al.
Publicado: (2018) -
Subcellular localization of DJ-1 in human HL-60 leukemia cells in response to diallyl disulfide treatment
por: Li, Qingye, et al.
Publicado: (2016) -
Diallyl disulfide effect on the invasion and migration ability of HL-60 cells with a high expression of DJ-1 in the nucleus through the suppression of the Src signaling pathway
por: Liu, Ran, et al.
Publicado: (2018) -
Treatment of Saos-2 osteosarcoma cells with diallyl trisulfide is associated with an increase in calreticulin expression
por: Xie, Wen-Peng, et al.
Publicado: (2018) -
Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer
por: Su, Bo, et al.
Publicado: (2016)